COVID-19 vaccines: How will availability impact healthcare recovery?

In 2020, the COVID-19 pandemic impacted the fundamentals of all healthcare stakeholders, whether due to lockdowns, procedure deferrals, clinical trial pauses, and M&A challenges. One of the most critical impacts has been that stakeholders do not have historical data that would allow them to better understand how the world will emerge from this crisis, and how recovery will unfold for healthcare stakeholders. Despite continued public health measures in 2021, the emergence of a number of vaccines in late 2020 and the rollout of these vaccines globally will determine how healthcare markets recover in 2021 and beyond.

In this whitepaper, we will explore 2020 impact and recovery insights, go over current vaccine development status and the various distinctions between different vaccines, then outline how we believe the vaccination campaigns will roll out globally and how we are incorporating that into our forecasting, followed by our analysis on the impact of vaccination availability on healthcare markets and sectors.